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Abstract
Antibiotic usage has become very widespread, as they are used to treat so many infectious diseases today. Antimicrobial 
agents exert their actions via different mechanisms including blockage of cell wall synthesis, interference of protein and/
or nucleic acid synthesis, interruption of cell membrane structure, and inhibition of a metabolic pathway. The treatment 
of bacterial infections with antimicrobial agents has become more difficult due to the capability of bacteria to develop 
resistance to antibiotics. Erroneous diagnosing, misconceptions, and improper physician-patient dynamics have led 
to overuse of antibiotics and the emergence of drug-resistant bacteria. Bacterial colonies have been shown to confer 
advantageous genetic information with ease, which is cause for concern. This, in turn, leads to a heightened urgency 
to create new forms of treatment that are effective against a greater proportion of a given bacterial colony. Effective 
ways of decreasing resistance include better diagnostic techniques, proper education and assessments, optimization of 
antibiotics usage, drug synergism, vaccine implementation, global efforts to combat resistance, and development of new 
antimicrobial agents.
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where antibiotics are regulated, they are available for online 
purchase [3,4].
Lack of optimization
In 30-50% of patients, treatment indication, choice of an-
tibiotic, or duration of therapy is inappropriate [5,6]. Incor-
rectly prescribed antibiotics have questionable therapeutic 
benefit and expose patients to potential complications of an-
tibiotic therapy [7].
In an outpatient setting, antibiotics are most often pre-
scribed for respiratory tract infections, which are caused by 
viruses. However, antibiotics usage continues to increase de-
spite it provides little benefit [8]. Antibiotics overuse for re-
spiratory tract infections were more common in the private 
sector than in the public sector [9].
Introduction
Pathogenic microorganisms have negatively affected hu-
man health throughout history. A significant percentage of 
human population has been affected by bacterial infections 
(e.g., bubonic plague and tuberculosis) and non-bacterial in-
fections (e.g., malaria and HIV) pandemics [1].
With the discovery of penicillin and some other classes of 
antibiotics in twentieth century, they were considered mir-
acle drugs. However, in the twenty-first century, antibiotics 
are still being used, but with much less success. Many factors 
contributed to antibiotic resistance that made the antibiotics 
less effective.
Contributing Factors for Bacterial Antibiotic 
Resistance
Antibiotics overuse
Antibiotics are now being prescribed more frequently 
than ever before. The overuse of antibiotics evidently influ-
ences the evolution of resistance [2]. A direct relationship 
between antibiotic use as well as the rise and spreading of 
resistant bacterial strains exists [2,3].
Lack of regulations
In many countries, antibiotics are unregulated and avail-
able over the counter without a prescription. This lack of reg-
ulation results in antibiotics that are easily accessible, plen-
tiful, and cheap, which promotes overuse. Even in countries 
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microbiome. Most of the antibiotics given to livestock are ex-
creted in urine and stool, which is dispersed through fertiliz-
er, groundwater, and surface runoff [3,5,17-19].
Use of cleaning products
Some hygienic and cleaning products contain antibac-
terial products, which adversely affect the development 
of immunities to environmental antigens in both children 
and adults. This will have negative effects on immune sys-
tem and the normally non-virulent microorganisms may 
increase morbidity and mortality due to infections [4,20].
Setting
MRSA is becoming more common in intensive care units, 
and its importance has more than doubled in ten years [21]. 
While nosocomial strains have slowly been decreasing, com-
munity-acquired strains have been gradually expanding due 
to increase in mobility. With frequent domestic and inter-
national travel, the spread of diseases, including MRSA, has 
enhanced rapidly [21]. Drug-resistant E. coli infections have 
become more prevalent in hospitals, and there is a rise in 
drug-resistant infections in members of the public that had 
limited contact with the hospital setting. Studies shows that 
antibiotic-resistant E. coli infections have doubled, and peo-
ple with little healthcare contact contracting the disease 
faster than those that have regular contact. Between 2009 
and 2014, there has been more than a threefold increase in 
community-acquired infections [14]. C. difficile is the inflam-
mation of the colon due to a bacterial infection and is linked 
with prior antibiotic use. In recent years, an antibiotic-resis-
tant strain has been spreading; causing more serious disease, 
failure in treatment, and death [22].
Mechanisms of Antibiotics Resistance
In bacteria, genes can be inherited from relatives or at-
tained from nonrelatives. This horizontal gene transfer (HGT) 
can allow antibiotic resistance to be transferred among dif-
ferent species of bacteria. Resistance can also occur sponta-
neously through mutation [1,2].
Antibiotics targeting cell wall
Antibacterial agents can inhibit cell wall synthesis by in-
terfering with the enzymes required for the synthesis of the 
peptidoglycan layer or by binding to the terminal D-alanine 
residues of the nascent peptidoglycan chain. These antibiot-
ics include β-lactams and the glycopeptides [23-25]. Bacteria 
have developed different resistance mechanisms against this 
class of antibiotics. β-lactamases hydrolyze nearly all β-lact-
ams that have ester and amide bond [26].
Class A β-lactamases are penicillinase and are clavulanic 
acid susceptible, which are found in members of Enterobac-
teriaceae [27].
Class B β-lactamases are resistant to inactivation by 
clavulanate, sulbactam, aztreonam, and carbapenems [28].
With exception of Salmonella and Klebsiella, all Gram-neg-
ative bacteria produce class C β-lactamases, which are im-
mune to all β-lactams except carbapenems. They are not in-
Factors associated with healthcare professionals
Physicians tend to use broad-spectrum agents with the 
wrong dose and frequency for the majority of common 
infections [10]. Incorrect prescribing of antibiotics can be 
caused by errors in diagnosis. A research study of patients 
with urinary tract infections showed that the physicians 
do not prescribe antibiotics based on specific signs and 
symptoms of UTI because of lack of proper documenta-
tion, and inadequate knowledge of proper antimicrobial 
agents [11]. In some countries like India, pharmacists copy 
doctor’s prescriptions, then prescribe and dispense antibi-
otics themselves for respiratory tract infections [9]. Spe-
cialist physicians prescribe antibiotics less often because 
they have updated knowledge about the indication of an-
tibiotics and access to government facilities with large in-
frastructures. Antibiotics are most commonly prescribed in 
rural areas. The practice of overprescribing is less common 
in the private urban setting and least common in a public 
setting [12].
Factors associated with patients
The biggest section of population for heavy antibiotic 
users are children and elderly [10]. A patient’s knowledge 
and assumption about a specific illness may influence the 
expectations to receive antibiotics. The expectation in-
creases if the patient assumes to have a bacterial infection 
[13]. Younger patients with a higher socioeconomic status 
are associated with antibiotic overuse [13]. The majority 
of patients believe that their risk of bacterial resistance 
increases if they take an antibiotic on a regular basis and 
they are not at risk if they are not on any antibiotics [14]. 
A survey of knowledge of antibiotics and antibiotic resis-
tance in France showed that despite media awareness 
campaigns, the overall public knowledge remains low [15]. 
Some studies show that patients are more satisfied with 
a careful clinical examination, explanation of diagnosis, 
reassurance by the physician, and a discussion about the 
reason for antibiotic prescription [9,13].
Doctor-patient relationship
Surveys show that physicians overprescribing antibiotics 
for many reasons including patients’ satisfaction, fear of pa-
tients’ health deterioration, keeping the patients from leaving 
for another doctor, patients’ expectation to receive antibiot-
ics, uncertainty in diagnosing the infection as viral or bacte-
rial, lack of established doctor-patient relationships, pressure 
from patients, work responsibilities, and the personalities of 
physicians. Older and the more senior physicians that were 
working in private practice were more likely overprescribing 
antibiotics. In addition, doctors in private practice are pre-
scribing more often to keep patients, while the doctors in 
public practice are overprescribing in order to save more time 
due to their busy schedule [8,9,16].
Use in agriculture
In many countries around the world, antibiotics are used 
in livestock to promote growth and prevent infection. The 
agricultural use of antibiotics also affects the environmental 
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which results in the leakage of bacterial contents. Daptomy-
cin inserts its lipid tail into the bacterial cell membrane, caus-
ing lethal bacterial membrane depolarization [43,44].
Resistance to polymyxins is seen in some Gram-negative 
species, such as Neisseria meningitidis, Proteus mirabilis and 
Burkholderia spp. These bacteria change the lipopolysaccha-
ride (LPS) structure, as polymyxins initially interact with the 
negatively charged lipid A component of LPS [45].
Role of Antibiotics on Microenvironment and 
Immune Response
Broad-spectrum antibiotics have a multitude of effects 
on the microenvironment of mammalian cells. Antibiot-
ics can have negative impacts on mitochondrial function, 
which may translate to compromised metabolism and 
cellular respiration. This was seen in a 2017 paper which 
showed that the normal electron transport and respiratory 
activity in mouse macrophages are inhibited by common 
antibiotics. This finding also has further implications. An-
tibiotics may have tissue-specific effects on different indi-
viduals, depending on their dynamic and personal micro-
environment. An example of this potential specificity was 
demonstrated when data indicated a depletion of meta-
bolic intermediates in the peritoneum of mice. The study 
then went on to see how metabolic inhibition would affect 
immune cells like phagocytes. Overall, the phagocytic kill-
ing of pathogens and the metabolic potential of common 
immune cells that respond to sites of infection was dimin-
ished. By inhibiting normal metabolism in cells, antibiotics 
can impede the production of necessary secondary mes-
sengers that play vital roles in immune and inflammato-
ry cascades. The metabolic changes made in the host by 
antibiotics can ultimately lead to a decrease in the drug’s 
efficacy. This study also reiterated the negative changes in 
the microbiomes of hosts taking antibiotics [46].
Patients that are frequently prescribed broad-spectrum 
antibiotics may be at risk of suppressing their immune sys-
tem. It is well understood that the brunt of the immune 
system is located in the gut and is formed by the microbi-
ome. Ironically, prescription antibiotics that are designed 
to treat illness and infection may compromise the immune 
response in some patients, if they are used gratuitously. 
This is discussed in a 2013 paper by Ubeda and Pamer, 
which contends that antibiotics will impact the production 
of antibodies, T-cell differentiation, and the expression of 
antimicrobial peptides that are found in intestinal epithe-
lial cells. These effects, in concert, can leave the immune 
system vulnerable to subsequent attacks [47].
Another study focused on the effects of antibiotics 
on white blood cell count and sought to determine if the 
change in WBC count was due to the normal rebound of 
the immune system, or if it was directly caused by common 
antibiotics. Total WBC count of participants was compared 
before and after antibiotics were administered. According 
to their results, certain antibiotics can diminish absolute 
neutrophil count, which is the most prevalent of the five 
classes of WBCs [48].
hibited by clavulanate [29,30].
Class D β-lactamases are found in Enterobacteriaceae and 
in P. aeruginosa. These bacteria produce oxacillin-hydrolyzing 
enzymes, which give resistance to penicillin, cloxacillin, oxa-
cillin, and methicillin. They are weakly inhibited by clavulanic 
acid [31].
Inhibitors of protein biosynthesis
Antimicrobial agents inhibit protein biosynthesis by tar-
geting the 30S or 50S subunit of the bacterial ribosome. Ami-
noglycosides and tetracyclines inhibit 30S ribosomal subunit. 
Chloramphenicol, macrolides, and oxazolidinones inhibit 50S 
subunit of ribosome. Alteration of 30S and 50S ribosomal 
subunits affects protein synthesis and results in antibiotic re-
sistance [32-36].
S. aureus, E. faecalis, and S. pneumoniae strains produce 
aminoglycoside-modifying enzymes (AMEs), which neutralize 
aminoglycosides by decreasing the affinity of a modified mol-
ecule and disrupting the binding to the 30S ribosomal subunit 
[37,38].
In tetracycline resistance, tet genes encode efflux proteins 
in Gram-positive and Gram-negative bacteria and affect new 
membrane transporters [39].
Chloramphenicol transacetylase enzyme is produced by 
some Gram-positive and Gram-negative bacteria and some 
of Hemophilus influenzae strains, which prevents the modi-
fied chloramphenicol from binding to a ribosomal 50S subunit 
[40].
In macrolide resistance, erm-encoded methylases in S. au-
reus, S. pneumoniae, and S. pyogenes cause methylation of 
ribosomal active site with reduced binding. In addition, Mef 
type pump has been explained as a mechanism of resistance 
for S. pneumoniae, and S. pyogenes against macrolides [39]. 
In oxazolidinones resistance, E. faecium and S. aureus 
cause mutation of target site, which leads to reduced binding 
to active site [39].
Folic acid metabolism inhibitors
Sulfonamides and trimethoprim inhibit specific steps of 
folic acid metabolism in bacteria [41]. E. coli, S. aureus and 
S. pneumoniae cause mutation of genes encoding Dihydrop-
teroate synthase (DHPS) [39].
Interference with nucleic acid synthesis
Fluoroquinolones inhibit DNA synthesis by creating dou-
ble-strand DNA breaks during DNA replication, and Rifampin 
inhibits RNA synthesis [1,42].
Enteric Gram-negative bacteria and S. aureus cause mu-
tations in gyr A that results in decreased binding to active 
site(s). Mutations in gyr A and par C in S. pneumoniae, and 
Nor-A in S. aureus affect membrane transporters [1,39].
Disruption of bacterial membrane structure
Examples of this class include polymyxins and daptomycin 
[39]. Polymyxins increase bacterial membrane permeability, 
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and see what drug the infection is susceptible to. Pharma-
cists can see if a culture is resistance to a particular antibi-
otic and can recommend a different one [51]. In response 
to the increase of antibiotic-resistant bacteria, more hos-
pitals have created programs to help physicians and phar-
macists limit the use of antibiotics [51].
To reduce misconceptions and misguided expectations 
about the treatment with antimicrobial agents, it is import-
ant to improve the patient’s knowledge and attitude about 
the proper use of antibiotics [52]. A study in China showed 
that when performance data of physicians are available for 
public to view, the physicians appropriate prescribing behav-
ior gradually improves [55]. 
Diagnostic techniques
Before starting an empiric therapy with antibiotics, cul-
tures should be obtained, and the cultures should be used 
to assist the physician in adjusting therapy. It is essential 
to obtain a clean culture from sterile sites before the start 
of antimicrobial agents. If the culture is negative from the 
sterile site and the patient remains sick, supplementary 
tests e.g., CBC and differential or C-reactive protein should 
be obtained to guide the treatment [56].
In order to correctly diagnose an infection, several tests 
must be conducted in conjunction with applied physician in-
tuition, as no single test can diagnose an infection with total 
accuracy [57].
A genetic study concluded that no single gene can ac-
count for the presence of resistance in bacteria. Whole-ge-
nome sequencing can be used to understand the pathology 
of certain bacteria, in conjunction with diagnostic analysis, 
susceptibility, and current epidemiological research [58].
Reduction in use
Restriction of certain antibiotics in humans does decrease 
resistance, but it also increases the use of and the resistance 
to other antibiotics that are used instead. Continued rotation 
of antibiotics can help decrease resistance, but only within 
the facility [59]. 
Reduction in use of antibiotics in livestock results in a 
substantial decrease of resistant bacteria in livestock and 
humans; and the restriction does not have any negative 
effect on the production levels [60]. To reduce antibiotics 
overuse, fees can be implemented for agricultural use. The 
fees could be used for research and development of new 
methods of antibacterial treatment [61].
Optimization of use
The empiric therapy protocol should be standardized. 
If possible, use of broad-spectrum antibiotics should be 
minimized [56]. Antibiotics should be prescribed only to 
treat bacterial infections. Evaluation of biological markers 
may be necessary in some cases [61]. There is no need for 
prophylaxis against urinary tract infections, as they are 
treated easily and are generally rare [62]. Effective anti-
biotic prescribing requires proper drug selection, dosing, 
route of administration, and interval [63]. For many antibi-
Cost of Antibiotic Resistance
Health care cost significantly increase due to antibiotic-re-
sistant infections. Physicians have to use the more toxic and 
more expensive antibiotics to fight against bacterial infections 
[5,7]. Patients with resistant infections stay in the hospital 6.4 
to 12.7 days longer , require more doctors’ visits, and suffer a 
higher rate of long-term disability [5,20]. Antibiotic-resistant 
infections economic burden is as high as $20 billion in health 
care costs and $35 billion a year in lost productivity. In addi-
tion, the burden of families and communities increases due to 
lost wages and health care costs [4,20].
The Solution
New treatments and therapies are constantly being devel-
oped in order to overcome drug-resistant infections.
Vaccination
Vaccination is beneficial in preventing or reducing the 
incident of certain bacterial infections. The vaccination pro-
grams against Haemophilus influenzae and Streptococcus 
pneumoniae have been very effective in significantly reducing 
bacterial infection; however, there are some concerns about 
the emergence of bacterial resistance against these vaccines. 
Use of pneumococcal vaccines in children and elderly have 
dramatically reduced the occurrence of otitis media, sinusitis, 
pneumonia, sepsis, and meningitis. Through the use of these 
vaccinations, the rate of prescribing antibiotics has been 
declined [49,50]. Despite of widespread efforts to prevent 
MRSA, it has been tremendously difficult to develop a staph-
ylococcal vaccine. Development of vaccines against β-lact-
amases and transpeptidases in β-lactam-resistant bacteria 
has been difficult so far [51].
Patients education
Patient counselling usually have a positive impact on re-
ducing antibiotic overuse. Physician should emphasize pa-
tient compliance with antibiotic treatment. To increase com-
pliance, doctors should pay attention to the cost of medica-
tions, must maintain good communication with patients, and 
provide appropriate educational materials for them to read 
[52].
The groups of patients with higher levels of misconcep-
tions and lower levels of knowledge about the negative 
impact of antibiotics usage include persons of lower socio-
economic status, lower educational status, males, those in 
younger age groups, and the elderly. These patients should 
be a part of any educational efforts to improve their knowl-
edge about antibiotic misuse and reduce their expectations 
to receive antibiotic prescriptions when it is not clinically in-
dicated [53].
Role of healthcare professionals
Antibiotic misuse can be controlled by providing the 
physician with proper indications and information, a critical 
analysis of data, a description of basic antibacterial activity, 
and information regarding the epidemiology of acquired re-
sistance [54].
Doctors should be able to crossmatch culture samples 
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should create and implement a comprehensive plan to deal 
with antimicrobial resistance in healthcare, food industry, 
communities, soil and water. These plans should include 
infection prevention and control practices, appropriate 
access and use of antibiotics, bacterial resistance tracking 
systems, and improvement in diagnostic techniques. Glob-
al effort should also concentrate on developing new drugs, 
diagnostic methods, vaccines, and therapeutics to treat in-
fections [69]. 
In response to increasing drug-resistant bacteria strains, 
the World Health Organization called for a global response 
to the problem. The World Health Assembly recommended 
a global action plan to challenge antimicrobial resistance. 
This plan has five specific objectives, which include increase 
awareness and understanding of antimicrobial resistance, en-
hance knowledge using surveillance and research, decrease 
the incidence of infection, improve the use of antimicrobial 
agents, and increase investment in new medicines, diagnostic 
tools, vaccines and other interventions [70].
Future research studies
Through gene manipulation, non-pathogenic antibiotrophs 
can be engineered for pharmaceutical, agricultural, and clini-
cal applications. Their chemoattractant patterns could be em-
ployed to recognize antibiotic outflow, while their genomic 
profiles could help enhance CRISPR interference and could as-
sist the next generation of molecular cloning utilization [71].
Bacterial repellents including bio toxic and microtox-
ic inhibitors may be better than the current bactericidal 
approach. Such cytotoxin neutralizers can be very effec-
tive since they do not affect colony viability. With this ap-
proach, these agents do not activate resistance-favorable 
mutations, ultimately decreasing the spread of resistant 
genes [72-74].
Conclusion
Antibiotics have been overprescribed due to poor pa-
tient and physician education, internal and external pres-
sures, and increasing demands. The overuse of antibiot-
ics has led to the emergence of drug-resistant strains of 
bacteria. World health organization, Center for Disease 
Control and Infectious Disease Society of America recog-
nized bacterial resistance as a pandemic issue with disas-
trous consequences if the condition is not controlled in the 
near future. Our dependence on antibiotics for livestock 
and treatment of infectious diseases in humans are high. 
Unfortunately, the bacteria are evolving and becoming re-
sistant to the available antimicrobial agents. There is an 
urgent need for development of new antibacterial agents. 
Education of physicians about the appropriate indications, 
proper dosages, and route of administration are important 
factors to prevent overuse of antibiotics. In addition, phy-
sicians should educate their patients about the risk of un-
necessary antibiotic treatment. Global efforts to prevent 
infections and to invest in the new method of treatments 
are crucial. 
Although, there are some solutions currently available to 
otics, careful attention to serum levels is also required to 
improve efficacy while reducing toxicity [56].
Route of administration
When IV antibiotics are used only for serious infections, 
overuse of antibiotics can be prevented in unnecessary 
cases. The enteral route is the preferred option for less 
serious infections. Switching to enteral after IV may also 
be done. Intubation increases risk of infection and should 
also be avoided when possible. Duration of parenteral 
nutrition should be decreased and must be replaced with 
enteral nutrition when it is clinically possible [59]. Skin 
infections should be treated until the condition is cured. 
Drainage and debridement are required for invasive tissue 
infections before providing antibiotics. Vascular catheters 
increase risk of infection and they should be intermittently 
removed or inserted in a different location [64].
Monotherapy vs. combined therapy
There are conflicting studies about the effectiveness of 
monotherapy vs. combined therapy. Some other studies 
show that combination therapy is no more effective in fight-
ing superbugs than using a single antibiotic, while one exper-
iment showed that monotherapy was linked with a smaller 
risk of infection. Another study shows that combination ther-
apy has a reduced risk of resistance [65].
It is not always necessary to combine two gram-nega-
tive fighting antibiotics unless resistance levels happen to 
be high. Once the susceptibility of infection is known, the 
treatment should ideally be continued with only one anti-
biotic. The duration should be noted, for studies show that 
a shorter duration had a similar mortality rate, although 
there is a significant decrease in the rise of resistance [49].
Combined treatment with piperacillin, tazobactam, and 
meropenem, shows beneficial results in patients infected 
with MRSA. In addition, this combination didn’t produce 
resistance against the drug [14]. In a study involving the 
efficacy of doxycycline and benzoyl peroxide on treatment 
of acne, researchers found that antibiotics in combination 
with benzoyl peroxide can increase the effectiveness of 
treatment by reducing the necessary dosage or duration of 
antibiotic therapy [66].
Alternative options
Ultraviolet germicidal irradiation (UVGI) is an effective 
disinfectant against MRSA and can help facilitate healing 
wounds. However, the research was only on two strains of 
MRSA, so more research is needed to see if all strains show 
the same results [67].
NaOCl or bleach is effective against viruses, bacteria, 
spores, and fungi. So far, no bacterial resistance has been 
found. It is also inexpensive and widely available, allowing 
it to be a better treatment option for certain infections. 
Bleach baths is beneficial against infected atopic eczema 
and can be used to replace antibiotics [68]. 
Current global efforts
CDC recommends that countries around the world 
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deal with multi-resistant bacteria, complete eradication of 
these bacteria seems very difficult at this time. A promising 
approach is use of various antibiotics with different mecha-
nism of actions. Other solutions to fight drug-resistant strains 
and resistance overall include new diagnosing procedures, 
alternative treatments, vaccinations, bacterial genomics, and 
the restricted use of antibiotics for agricultural use. With a 
widespread commitment to resolving this problem, the immi-
nence of antibiotic resistance can be left in the past.
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